Aurinia Pharmaceuticals gains on speculation of Otsuka interest

Jul. 01, 2022 1:00 PM ETAurinia Pharmaceuticals Inc. (AUPH), OTSKFBy: Joshua Fineman, SA News Editor62 Comments

The concept of the word M&A on cubes on a beautiful green background

Zhanna Hapanovich/iStock via Getty Images

  • Aurinia Pharmaceuticals (NASDAQ:AUPH) rose 8% on speculation the company may be a target, though it's not clear who the buyer may be.
  • Aurinia (AUPH) could be a possible takeover target for Japanese pharma company Otsuka, according to a Betaville "uncooked" alert, which cited what some people are speculating.
  • The report comes as European-based MKT Tactical Fund, which owns around a 4.6% stake in Aurinia (AUPH), has been advocating for the company to make an announcement that it hired an investment bank to do a strategic review and possible sale to a large pharma, according to Betaville.
  • Recall late May, Aurinia Pharmaceuticals (AUPH) touted long-term benefit of Lupkynis for lupus.

Recommended For You

Comments (62)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.